Biomarker-matched drug combos shrink treatment-resistant melanoma in preclinical models

3 months ago 11
A caller survey led by researchers astatine The University of Texas MD Anderson Cancer Center has identified a mode to tailor cause combinations based connected circumstantial tumor biology to amended outcomes for treatment-resistant precocious melanoma.
Read Entire Article